reviewThe Lancet OncologyNov 30, 2016Closed access

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

MedStar Georgetown University Hospital · Georgetown University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,673
total citations
FWCI
57.54
Percentile
100%
References
77
Citations per year

Authors

3

Topics & keywords

Keywords
  • Immunotherapy
  • Biomarker
  • Medicine
  • Multiplex
  • Melanoma
  • Oncology
  • Immune checkpoint
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.